Turkish Journal of Medical Sciences
Volume 30

Number 6

Article 17

1-1-2000

Breast Carcinoma Showing Neuroendocrine Differentiation
Characterized with Ectopic Hormone Production (2 case reports)
GÜLAY ÖZBİLİM
BAHAR KILIÇARSLAN
EKMEL TEZER
AYLA BÜYÜKKEÇE
MELEK ÜSTÜN

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ÖZBİLİM, GÜLAY; KILIÇARSLAN, BAHAR; TEZER, EKMEL; BÜYÜKKEÇE, AYLA; ÜSTÜN, MELEK; KARAVELİ,
ŞEYDA; and OYGÜR, NEZİHİ (2000) "Breast Carcinoma Showing Neuroendocrine Differentiation
Characterized with Ectopic Hormone Production (2 case reports)," Turkish Journal of Medical Sciences:
Vol. 30: No. 6, Article 17. Available at: https://journals.tubitak.gov.tr/medical/vol30/iss6/17

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Breast Carcinoma Showing Neuroendocrine Differentiation Characterized with
Ectopic Hormone Production (2 case reports)
Authors
GÜLAY ÖZBİLİM, BAHAR KILIÇARSLAN, EKMEL TEZER, AYLA BÜYÜKKEÇE, MELEK ÜSTÜN, ŞEYDA
KARAVELİ, and NEZİHİ OYGÜR

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol30/iss6/17

Turk J Med Sci
30 (2000) 609-613
© T†BÜTAK

Short Report

1

GŸlay …ZBÜLÜM
1
Bahar KILI‚ARSLAN
3
Ekmel TEZER
2
Ayla B†Y†KKE‚E
1
Melek †ST†N
1
Þeyda KARAVELÜ
2
Nezihi OYG†R

1

Breast Carcinoma Showing Neuroendocrine
Differentiation Characterized with Ectopic
Hormone Production
(2 case reports)

2

Departments of Pathology, General Surgery,
Faculty of Medicine, Akdeniz University,
3
Antalya, Department of Pathology, Facilty of
Medicine SŸleyman Demirel University,
Isparta-TURKEY

Received: September 09, 1999

Neuroendocrine differentiation can be found in benign
or malignant lesions of various organ systems. In 1947,
Vogler indicated the existence of neuroendocrine cells in
mammary tissue (1). Recent studies have reported the
incidence of neuroendocrine differentiation in breast carcinomas as being between 3% and 21% (2). The existence of neuroendocrine differentiation was also shown in
male breast carcinomas (3). Neuroendocrine differentiation detected in breast carcinomas shows morphological
similarities to carcinomas of the gastrointestinal system,
lung, and other non-endocrine organs with endocrine differentiation and carcinoid tumours. In order to verify the
existence of these cells, in addition to morphological
examination, histochemical and immunohistochemical
staining is used. The presence of argyrophilic and electron-dense granules is usually sufficient (4,5). For
immunohistochemical staining, Neuron Specific Enolase
(NSE) and Chromogranin A are frequently used (6-9).
Rarely, hormone production of the tumor is also present,
the most common hormones being: ACTH, leucoencephalin, gastrin, pancreatic polypeptide, bombesin, serotonin, HCG, prolactin, vasointestinal polypeptide (VIP),
and luteinizing hormone releasing factor (5,10,11,12).
In this study, two cases of breast carcinoma showing
neuroendocrine differentiation and ectopic hormone
secretion are presented together with their histochemical
and immunal staining properties.

Key Words: Neuroendocrine differentiation,
ectopic hormone production, breast
carcinoma

Case Reports
Case 1 (Case A): A sixty-seven-year-old patient was
admitted to a medical center complaining of a mass in her
right breast. After a biopsy, "invasive lobular carcinoma"
was diagnosed and her mastectomized tissue was sent to
the pathology department for consultation and the determination of prognostic factors. An examination of her
organ systems did not reveal any pathological findings.
Macroscopic findigns: Tumors were found in two foci
on the examination of thin sections of the mastectomized
tissue. The tumor tissues were hard in consistency, and
gray-white in color. One of them was under the areola,
and the other was in the lower medial quadrant. Their
diameters were 2.7 and 3cm respectively. Two lymph
nodes in the central axilla and one node in the midaxilla
were found to be involved by macroscopy.
Microscopic findings: Paraffin slides were prepared
from the tumor foci, from all quadrants, and the lymph
nodes were evaluated by light microscopy. The tumor
was made up of tubular and organoid structures consisting of atypical cells with oval and round hyperchromatic
nuclei. Grimelius staining revealed argyrophilic granules in
the tumor cells. Immunohistochemically, chromogranin A,
NSE and S-100 were found to be positive (Fig.2). Since it
has been reported that estrogen, progesteron, ACTH,
HCG and prolactin can also be positive in these tumors,
related stains were applied immunohistochemically. The
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Figure 1.

Microscopic appearance of breast carcinoma with neuroendocrine differentiation (HE; x 20)

results for these stains and other immunohistochemical
stains used as determining prognostic factors are given in
Table 1. This patient had two metastatic lymph nodes dissected from the central axilla.
Case 2 (Case B): A sixty-seven year-old patient (C.T.)
was admitted to the outpatient clinics of the General
Surgery Department of our medical school after she
noticed a mass in her right breast. The mass, which was
localized in the upper lateral quadrant of the right breast,
was excised. The patient had been treated for essential
hypertension for 30 years. There were no other pathological findings in her organ systems.
Macroscopic findings: The dimensions of the material
sent to the pathology department were 3x2.5x1.2 cm. It
was covered with mature fat tissue. When dissected, a
tumoral mass of gray-white color, hard in consistency,
with irregular borders, and 1.5 cm in diameter was
found. All of the tissue was examined.

Table 1.

Figure 2.

Immunohistohemical stain for Chromogranin A in breast
carcinoma with neuroendocrine differentiation (Chromogranin A; x20).

Macroscopic findings: It was noted that the structures
of mammary tissue observed in mature fat tissue disappeared in large areas and transformed into tumor tissue.
The tumor was made up of organoid structures consisting of atypical cells with oval, round, and hyperchromatic nuclei, and narrow cytoplasm, showing rare mitosis. In
order to check for the existence of argyrophilic granules,
Grimelius stain was applied histochemically and it was
found to be positive in wide areas or most areas. The
results of S-100, NSE, chromogranin A and ACTH, prolactin, HCG estrogen, and progesteron and other
immunohistochemical staining applied are shown in Table
2 (Figures 3 and 4).
Both cases were diagnosed as breast carcinomas
showing neuroendocrine differentiation according to the
results of histochemical and immunohistochemical staining and histopathologic findings obtained by light
microscopy. Fifty-micron-thick slices prepared from
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The results of immunohistochemical stains of B case.
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Figure 3.

Immunohistochemical stain for HCG in breast carcinoma
with neuroendocrine differentiation (HCG; x 40).

paraffin blocks of the specimens were digested with
0.5% pepsin after being treated in xylene and alcohol.
The nuclei were washed by PBS and stained with propidium iodide. The DNA content was measured by an ICS-22
flow cytometry instrument. It was found that the cells of
Case 1 were in the diploid cycle (Fig.5), whereas 83.8%
of the cells of Case 2 were in the diploid cycle and 16.2%
were in the aneuploid cycle (Fig.6). The S phases of Case
1 and Case 2 were found to be 6.1% and 13.2% respectively.
We observed that Case A, whose tumor was multifocal and had a diameter of 3 cm, showed positive reactions
to p53, Cat-D, and PCNA stains. She had metastases in
two lymph nodes. Macroscopically, in Case B, whose
tumor was 1.5 cm in diameter, p53 was negative, PCNA

Figure 4.

Immunohistochemical stain for estrogen receptors in breast
carcinoma with neuroendocrine differentiation (Estrogen; x
40).

was one positive (+) in 5% of the areas; Cat-D, c-erbB2,
and UEA-1 lectin were significantly positive. DNA analyses
of these patients revealed that the cells of Case A were
diploid, while the cells of Case B were 83.8% diploid and
16.2% aneuploid.

Discussion
Breast carcinomas containing neuroendocrine cells
used to be known as argyrophilic breast carcinomas or
breast carcinoid tumors, but are now classified as "breast
carcinomas with neuroendocrine differentiation" (2,13).
The incidence of neuroendocrine differentation in
breast carcinomas is between 3 and 21% (2,4,13,14),
and the existence of neuroendocrine cells in ductal and
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lobular carcinomas has also been reported (2,4,5,13,14).
One study suggested that there are no neuroendocrine
cells in normal breast tissue (5,15); however, in another
study, a small number of neuroendocrine cells were
determined in normal breast ducts (16).
Breast carcinomas showing neuroendocrine differentiation are histopathologically similar to the carcinoid
tumors of the digestive and respiratory tracts. However,
they are morphologically and clinically different from the
classical carcinoid tumors of other systems (5,17).
Grimelius staining is specific and shows argyrophylic
granules to prove the existence of neuroendocrine cells in
these tumors (14). The immunohistochemical reactivity
of NSE is a useful indicator (6). However, in some normal
breast tissues, myoepithelial cells show a weak positive
reaction with NSE. Therefore, positivity determined with
NSE should be supported by other findings (6). Fifty to
eighty-six percent of breast carcinomas showing neuroendocrine differentiation exhibit chromogranin A positivity immunohistochemically (12,18).
Histopathological examination of both of our patients
made us consider the presence of neuroendocrine differentiation because of the existence of solid and tubular
structures of groups of uniform cells with oval and round
hyperchromatic nuclei, and narrow cytoplasm, showing
rare mitosis. Neuroendocrine granules were observed by
means of the histochemical stain of Grimelius. Immunohistochemically applied NSE demonstrated two and three
positive staining concentrations in 80% of areas in both
patients. Chromogranin A was found to be two positive in

70% of areas in Case A and one positive in 20% of areas
in Case B. The prognostic parameters p53, Cat-D, PCNA,
c-erbB2 and UEA-1 lectin were applied to both cases. It
was reported that Case A had been mastectomized at
another hospital and she did not have any lymph node
metastases. The synthesis phases in both cases were
found to be low: in Case A, S%, 6.1; in Case B, S%, 13.2.
In a previous study, it was reported that in NSE positive
grade 1 neuroendocrine tumors there was aneuploidy,
whereas in the NSE negative group there was diploidy
(19).
In rare cases of tumors showing neuroendocrine differentiation, hormone production occurs (8,11). Estrogen, ACTH, epinephrin, gastrin, prolactin, luteinizing hormone and HCG are the hormones which can be determined. Estrogen and progesteron were investigated
immunohistochemically. It was found that, in A there was
ACTH and prolactin, while in B there was progesteron in
addition to estrogen and HCG, which were determined in
bot cases. In these cases no clinical findings were
observed which were in accordance with what has been
reported in the literature as a result of hormone production (7) There was no evidence of recurrence postoperatively (24 months for Case A and 29 months for Case B).
These two cases, which exhibited neuroendocrine differentiation in the tumors and ectopic hormone production, were presented together with histochemical and
immunohistochemical findings and the results of flow
cytometry because of their rarity.
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